Albemarle Corp
NYSE:ALB
Albemarle Corp
NYSE:ALB
Price:
162.44
USD
2.67%
Market Closed
Market Cap:
$19.1B
Relative Value
The Relative Value of one
ALB
stock under the Base Case scenario is
74.71
USD.
Compared to the current market price of 162.44 USD,
Albemarle Corp
is
Overvalued by 54%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
ALB
Relative Value
Base Case
74.71
USD
Overvaluation 54%
Multiples Across Competitors
ALB Competitors Multiples
Albemarle Corp Competitors
Albemarle Corp Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Albemarle Corp
NYSE:ALB
|
19.1B USD | 3.7 | -28.2 | 27.8 | 249.4 | |
| US |
|
Sherwin-Williams Co
NYSE:SHW
|
79.9B USD | 3.4 | 31.1 | 20.2 | 23.8 | |
| US |
|
Ecolab Inc
NYSE:ECL
|
77B USD | 4.8 | 37.1 | 21.5 | 28.8 | |
| JP |
|
Shin-Etsu Chemical Co Ltd
TSE:4063
|
12.2T JPY | 4.8 | 25.1 | 12.3 | 17 | |
| JP |
Y
|
Yasuhara Chemical Co Ltd
TSE:4957
|
10.8T JPY | 1 | 10.5 | 5.8 | 7.1 | |
| CN |
|
Wanhua Chemical Group Co Ltd
SSE:600309
|
256.5B CNY | 1.4 | 23.1 | 20.1 | 20.1 | |
| CH |
|
Givaudan SA
SIX:GIVN
|
26.2B CHF | 3.5 | 24.4 | 17 | 21.6 | |
| DK |
|
Novozymes A/S
CSE:NZYM B
|
165.6B DKK | 9.3 | 54.8 | 28.9 | 37.9 | |
| IN |
|
Asian Paints Ltd
NSE:ASIANPAINT
|
2.1T INR | 6.1 | 55.1 | 33.1 | 40.6 | |
| US |
|
PPG Industries Inc
NYSE:PPG
|
23.1B USD | 1.5 | 14.7 | 10.2 | 12.8 | |
| CH |
|
Sika AG
F:SIKA
|
19.9B EUR | 1.6 | 17.3 | 10.2 | 14.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
